Philip Morris International | 8-K: Current report
Philip Morris International | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Philip Morris International | 4: Statement of changes in beneficial ownership of securities-Director Calantzopoulos Andre
Philip Morris International | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Philip Morris International | 8-K: Current report
Philip Morris International | 4: Statement of changes in beneficial ownership of securities-Officer Volpetti Stefano
Philip Morris International | 424B2: Prospectus
Philip Morris International | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Philip Morris International | 144: Notice of proposed sale of securities pursuant to Rule 144
Philip Morris International | 424B2: Prospectus
Philip Morris International | 4: Statement of changes in beneficial ownership of securities-Officer Barth Werner
Philip Morris International | 4: Statement of changes in beneficial ownership of securities-Director Calantzopoulos Andre
Philip Morris International | 4: Statement of changes in beneficial ownership of securities-Officer De Wilde Frederic
Philip Morris International | 10-Q: Q3 2024 Earnings Report
Philip Morris International | 144: Notice of proposed sale of securities pursuant to Rule 144
Philip Morris International | 144: Notice of proposed sale of securities pursuant to Rule 144
Philip Morris International | 144: Notice of proposed sale of securities pursuant to Rule 144
Philip Morris International | 8-K: Philip Morris Reports Third Quarter 2024 Financial Results
Philip Morris International | 8-K: Philip Morris Proposes CCAA Plan to Address Claims and Litigation Related to Tobacco Products in Canada
Philip Morris International | 8-K: Philip Morris Announces Sale of Its Subsidiary Vectura Fertin for $198 Million
No Data
No Data